Sanara MedTech (SMTI) Shares Outstanding (Weighted Average) (2010 - 2026)

Sanara MedTech (SMTI) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1.59% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 1.59% YoY), and the FY2025 full-year result was $8.6 million, up 1.64% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $8.7 million, up from $8.6 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $8.7 million in Q1 2026 and bottomed at $7.6 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $8.4 million (2024), against an average of $8.3 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) gained 11.59%; it then gained 1.52% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $7.9 million in 2022, then increased by 4.71% to $8.3 million in 2023, then climbed by 2.48% to $8.5 million in 2024, then advanced by 1.64% to $8.6 million in 2025, then advanced by 0.97% to $8.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $8.7 million (Q1 2026), $8.6 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.

Peer Comparison